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Introduction
Cigarette smoking is the single most important cause of 
avoidable premature mortality in the world, and quitting is 
known to rapidly reduce the risk of serious diseases (World 
Health Organization (WHO), 2008). Death is mainly 
caused by lung cancer, coronary heart disease, chronic 
obstructive pulmonary disease, and stroke (Doll et al., 
2004; US Department of Health Human Services, 2004). 
The risk of serious disease diminishes rapidly after quitting 
and permanent abstinence is known to reduce the risk of 
illness (Lightwood and Glantz, 1997; US Department of 
Health Human Services, 1990). Offering help to people 
addicted to nicotine is one of the six policies identified by 
the WHO Framework Convention on Tobacco Control 
(FCTC) to expand the fight against the tobacco epidemic 
(WHO, 2009). However, smoking cessation turned out to 
be anything but simple, and for this reason, more and more 
clinicians and researchers consider it a complex learning 
process by nature (Lee et al., 2012).
Unfortunately, about 80 percent of smokers have no 
immediate intention to quit (Herzog and Blagg, 2007).
The efficacy of smoking cessation interventions in vari-
ous clinical settings has been well documented, and studies 
have demonstrated that personal motivation (Curry et al., 
1989; Lennox and Taylor, 1994) and ongoing support 
(Sinclair et al., 1995) can further improve smoking cessa-
tion rates. Community pharmacies have increased the 
Training pharmacists in the stage-of-
change model of smoking cessation and 
motivational interviewing: A randomized 
controlled trial
Pasquale Caponnetto1,2, Jennifer DiPiazza3, Maria Rosaria Aiello4 
and Riccardo Polosa1
Abstract
This study evaluated the effect of training pharmacists in the stage-of-change model for smoking cessation and motivational 
interviewing on smoking cessation outcomes. A training based on the stage-of-change model for smoking cessation and 
motivational interviewing was introduced to pharmacists. Pharmacists were randomly assigned to the intervention or 
control group. The control group attended a 3-hour training session, whereas the intervention group also attended a 
further 6-hour training session. At week 24, 12.2 percent of the smokers quit smoking in the intervention group, whereas 
1.6 percent of the smokers quit smoking in the control group. The findings of this study showed that training pharmacists, 
in the stage-of-change model for smoking cessation and motivational interviewing, improves smoking reduction and 
cessation rates.
Keywords
adults, clinical health psychology, community health psychology, health promotion, nicotine dependence, public health 
psychology
1Università di Catania, Italy
2University of Stirling, UK
3City University of New York, USA
4Sofad Srl Catania, Italy
Corresponding author:
Pasquale Caponnetto, Centro per la Prevenzione e Cura del Tabagismo 
(CPCT), Azienda Ospedaliero-Universitaria “V.Emanuele-Policlinico,” 
Università di Catania, via S. sofia 78, 95100, Catania, Italy. 
Email: p.caponnetto@unict.it
736429 HPO0010.1177/2055102917736429Health Psychology OpenCaponnetto et al.
research-article20172017
Intervention Study
2 Health Psychology Open 
accessibility of smoking cessation treatments such as 
“over-the-counter” (OTC) nicotine replacement therapy 
(NRT). In a preliminary study focused on experiences of 
customers in a community pharmacy setting (Sinclair et al., 
1995), three-quarters of NRT users interviewed recalled 
having received some counseling from the pharmacist and/
or the pharmacy assistant, and almost all of these customers 
felt that the counseling was helpful. However, more than a 
quarter did not recall receiving any counseling, and most of 
these customers reported they would have valued some 
smoking cessation counseling from a pharmacist.
Most pharmacists are eager to undertake a leading role 
in health promotion (Bond et al., 1993; Mertinez et al., 
1993; National Audit Office, 1992). However, concerns 
have been raised that pharmacists are not trained for smok-
ing cessation counseling and their advice may conflict with 
advice given from a patient’s general medical practitioner 
(Eaton and Webb, 1979; Roberts, 1988).
Training hospital doctors, general practitioners, and 
nurses in promoting and sustaining behavioral change 
among their patients has been shown to be effective for pro-
moting smoking cessation (Cornuz et al., 2002; Tønnesen 
et al., 2007; Wallace-Bell, 2003).
This randomized controlled study, conducted in pharma-
cies in Sicily, Italy, evaluated the effect on pharmacy cus-
tomers’ cessation outcomes when pharmacists were trained 
in the stage-of-change model for smoking cessation (Di 
Clemente, 2001) and motivational interviewing (MI) 
(Miller and Rollnick, 2013).
In this model, proposed by Prochaska and Di Clemente 
and colleagues, change is conceptualized as a process 
occurring in five stages: precontemplation, contemplation, 
preparation for action, action, and maintenance. In the con-
text of cigarette addiction, the stage-of-change model pro-
poses “stage-matched interventions” to treat cigarette 
addiction. It is hypothesized that smokers progress linearly 
through the five stages and may relapse to earlier stages. 
Each stage is characterized by the presence of divergent 
beliefs and attitudes toward smoking behavior. This model 
may assist in determining the type and range of interven-
tions required by pharmacy personnel and tailoring inter-
ventions to the smoker’s current stage which may increase 
their likelihood of quitting (Di Clemente, 2001).
MI is widely used to help smokers quit. It is a patient-
centered counseling approach for helping people to explore 
and resolve their ambivalence about changing their smok-
ing behavior. Evidence suggests that MI by general practi-
tioners and trained counselors motivates patients toward 
change (Miller and Rollnick, 2013). There is also evidence 
that MI may be more efficacious relative to other treat-
ments with smokers who are low in motivation to quit 
(Hettema and Hendricks, 2010).
Customers seeking help with smoking cessation from 
pharmacy personnel are already beyond the “precontempla-
tion” stage of the stage-of-change model. Rather, these 
customers are people who have reached the “contemplation” 
or “preparation” stage and may be intending to purchase a 
smoking cessation aid. For smokers who decide to stop 
smoking, pharmacotherapy increases the chances of success 
(Fiore et al., 2008). An understanding of the theory and prac-
tice of the stage-of-change model and MI could result in 
more effective counseling, by pairing the appropriate cessa-
tion advice to the stage of each customer and helping them 
resolve their ambivalences toward change. Well-designed 
smoking cessation training for pharmacists is needed. To the 
best of our knowledge, this is the first study designed to 
assess the outcome of training pharmacists in the stage-of-
change model of smoking cessation and MI.
We hypothesized that pharmacists who participated in a 
training based on the stage-of-change model and MI would 
be more effective than untrained controls to help people 
quit smoking and that many of their customers would 
achieve long-term abstinence from smoking. Hence, the 
main objective of this study was to evaluate the effect of the 
training on smoking cessation outcomes. The training 
included specific content and recommendations pertaining 
to preparation, action, maintenance, and relapse.
The focus of the training was to help participants develop 
an understanding of the key principles of the stage-of-
change model and MI approach. Participants learned a series 
of brief questioning to assess the stages of change of their 
customers. Strategies to match the stage to the most appro-
priate intervention to promote cessation were emphasized.
Methods
A training based on the stage-of-change model of smoking 
cessation (Di Clemente, 2001) and MI (Miller and Rollnick, 
2013) was conducted in February 2016, by the Centro per 
la Prevenzione e Cura del Tabagismo at the University of 
Catania. The training was previously piloted on a cross sec-
tion of pharmacy personnel. Case studies of pharmacy cus-
tomers, communication skills for negotiating change, and 
the importance of providing ongoing support, encourage-
ment, and pharmacotherapy for cessation were included 
and emphasized in the training.
In September 2015, all 46 community pharmacies regis-
tered at Farmacia OK, a Sicilian Pharmacists’ Association, 
were invited to participate in the trial. A total of 42 pharma-
cies accepted the invitation and attended a 3-hour confer-
ence focused on the US Public Health Services 2008 
Clinical Practice Guidelines for Treating Tobacco Use and 
Dependence (Fiore et al., 2008). These guidelines align 
with the principles of MI and the stage-of-change model. 
Training for pharmacists in Italy does not include smoking 
cessation. Therefore, it was critical to expose participants 
to these internationally accepted evidence-based practice 
guidelines for tobacco dependence.
Successively, pharmacies were randomly allocated, by 
sequential allocation, to the intervention or control group 
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(Figure 1). The intervention group attended a 6-hour 
training by scheduling an initiation workshop. The 
6 hours of anti-smoking training teach the most skilled 
pharmacists to be more effective in making them able to 
help their smoking customers quit.
During the 3-month customer recruitment period, all 
smokers who sought advice on smoking cessation or those 
who bought an OTC anti-smoking product in preparation 
for a new attempt to stop smoking were eligible for inclu-
sion. Pharmacy personnel offered these customers a patient 
information sheet specific to their group (intervention or 
control) informing them that Farmacia OK pharmacists 
were working with researchers studying smoking cessation 
at the University of Catania and inviting them to join the 
study. Specifically, in the intervention group, smokers were 
informed that their pharmacists were trained to specific 
anti-smoking counseling based on stage-of-change and MI 
theories. In the control group, smokers were informed that 
their pharmacists recently attended a conference on 
“Clinical Practice Guidelines for Treating Tobacco Use and 
Dependence.”
Pharmacy staff maintained a confidential client record 
which documented their progress in smoking cessation, any 
product supplied, points raised by the client, and advice 
given. At each of the planned follow-up visits, telephone 
call reminders were carried out to improve participation. 
However, customers were not made aware of their group 
allocation (intervention vs control pharmacy). To monitor 
the level of non-recruitment, pharmacies in both groups 
maintained a tally record of customers who declined to join 
the study and their reasons. Intervention personnel offered 
their customers the professional anti-smoking counseling. 
The control group asked customers to register and then 
continued to provide standard professional support.
The main outcome measures were number of treated 
smokers, smoking reduction at week 24, and smoking ces-
sation rates at week 24, in accordance with Russell 
Standard (Clinical) (West et al., 2005). Validation was 
covered by measuring exhaled carbon monoxide (eCO). 
Participants who self-reported quit smoking with an eCO 
concentration of ≤10 ppm at the week 24 follow-up visit 
were defined as quitters (21). Those smokers who failed 
to meet these criteria (smoking abstinence and eCO 
≤10 ppm) were categorized as smoking cessation failures 
(i.e. relapsers with eCO ≥10 ppm). Smokers setting a firm 
quit date was counted as “lost to follow-up” if, on attempt-
ing to determine and verify his or her quitter status, he or 
she could not be contacted. Success rates were measured 
as the 24-week (24WQ) success rate (West et al., 2005). 
At each follow-up time point, cigarette consumption was 
Figure 1. CONSORT flow diagram.
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assessed and counseling was offered. Abstinence from 
smoking was reviewed objectively throughout the study 
by measuring the levels of eCO at each follow-up visit.
The statistical software SPSS 16.0 (SPSS Inc., 2007) for 
Windows was used to store and analyze data, to calculate 
descriptive statistics, and to demonstrate differences 
between the intervention and control groups.
Data analysis
We use descriptive statistics (i.e. frequencies/percentages, 
means/standard deviations) to describe the intervention 
content (active vs control group). To describe process 
results in terms of patterns of quitting, we reported the 
smoking cessation rates. To describe process results in 
terms of cessation rates, we applied the Fisher test. We used 
intention-to-treat analysis in the context of analysis of vari-
ance (ANOVA) and applied the Wilcoxon/Mann–Whitney 
test assuming that all those smokers who were lost to fol-
low-up were classified as failures.
Results
All 46 community pharmacies registered at Farmacia OK, a 
Sicilian Pharmacists’ Association, were invited to participate 
in the trial; a total of 42 community pharmacies registered in 
the Farmacia OK database have participated in the trial. In 
all, 21 pharmacies were randomly allocated by sequential 
allocation to the intervention group and 21 to the control 
group; 13 pharmacies of the intervention group completed 
the study and 8 pharmacies of the control group completed 
the study. Pharmacies that did not complete the study were 
contacted by telephone from the principal investigator’s 
study to know the reasons that prompted them not to com-
plete the project. About 35 percent responded that they had 
other priorities to follow at that time, 25 percent replied that 
they did not have enough staff dedicated to the project, 
20 percent responded that they did not complete the study for 
the fear of losing customers in the event of a smoking cessa-
tion treatment’s lack of effectiveness, and 20 percent replied 
that to help smokers takes time and their pharmacy must 
always be quick and fast so they cannot waste time.
A total of 187 smokers were enrolled in the study (124 
smokers were enrolled in the intervention group and 63 
smokers were enrolled in the control group; Figure 2).
At week 24, we have observed a significant reduction in 
the number of daily cigarettes smoked between the inter-
vention and control groups. The intervention group smoked 
a mean of 22.4 cigarettes per day at recruitment versus a 
mean of 7.5 cigarettes per day at week 24. The control 
group smoked a mean of 17.3 cigarettes per day at recruit-
ment and 12.5 cigarettes per day at week 24 (Figure 3).
Assuming that all those individuals who were lost to 
follow-up were classified as failures (intention-to-treat anal-
ysis), in the context of ANOVA, we applied the Wilcoxon/
Mann–Whitney test and showed that the difference between 
baseline and week 24 between the intervention and control 
groups resulted statistically significant. In the control group, 
difference between cigarettes in baseline and week 24 was 
−0.88 (p = 0.001), while in the intervention group, a reduc-
tion in −4.82 (z = −4.028; p = 0.000) was observed.
To valuate cessation rates, we applied the Fisher test and 
we observed 12.2 percent of smokers quit smoking in the 
intervention group at week 24, and 1.6 percent of smokers 
quit smoking in the control group (F = 0.001) (Figure 4). 
Finally, at week 24, the possibility to quit smoking in the 
intervention group was 1.48 times greater than the control 
group (odds ratio = 1.252–1.761).
Discussion
When a smoker reaches the contemplation stage of smoking 
cessation, he or she can ask for help from the pharmacists. 
He or she represents a reference point for his or her ease of 
accessibility and a reference point for the pharmacist–patient 
Figure 2. Numbers of smokers enrolled in the study.
Figure 3. Smoking reduction.
Caponnetto et al. 5
relationship. Customers generally interact with pharmacists 
often and have great esteem and confidence in pharmacists, 
and 86.4 percent of pharmacists believe that their profession 
should become more active in helping patients to quit smok-
ing (Hudmon et al., 2006). Hence, it is very important to 
have the proper training, to give the right advice to these peo-
ple who are often not well assisted. In Scotland, Coggans 
et al. (2000) documented that 66 percent of the surveyed 
pharmacy patients agreed that they would be willing to dis-
cuss tobacco cessation with a community pharmacist. 
Brewster et al. (2007) surveyed more than 2000 Ontarians, 
one-third of whom thought that their pharmacist would be a 
good source of tobacco cessation advice. Also, in one of the 
two studies conducted in the United States, Hudmon et al. 
(2003) interviewed NRT users who had either recently quit 
(75% of respondents) or were about to do so. A majority 
(63%, n = 103) believed that assistance or advice from a 
pharmacist would increase the chance of success in quitting. 
In the other study, of the 73 patients who completed a survey, 
those who smoked (n = 20) agreed or strongly agreed (85%) 
that pharmacies were the most convenient places for tobacco 
cessation programs (Hudmon et al., 2003). Moreover, a 
majority of smokers believe that community pharmacies are 
a convenient location for receiving cessation services 
(Couchenour et al., 2002). Research strongly suggests that 
pharmacist-led tobacco cessation interventions in commu-
nity settings are effective. Our study showed higher effec-
tiveness of pharmacists trained in stage-of-change model on 
smoking cessation and MI to help smokers quit smoking 
compared to control group. Because of its design, there are a 
number of limitations that must be considered when inter-
preting the findings of this study (e.g. the small sample size). 
Some characteristics of the sample limit generalization of the 
findings; all participants were regular smokers with an ele-
vated level of nicotine dependence (≥10 cigarettes per day), 
they were motivated to quit, and all participants were adults 
and customers of “Farmacia OK group.” Finally, the findings 
reported from urban Sicilian residents in this study may not 
be valid for other population samples. Nonetheless, our study 
indicated that training pharmacists in the stage-of-change 
model of smoking cessation and MI in a smoking cessation 
program is an inexpensive strategy that can be quite effective 
for smokers. This can represent a good starting point for new 
studies to improve smoking cessation intervention delivered 
by pharmacists.
Conclusion
This study showed the importance to training pharmacists in 
the stage-of-change model of smoking cessation and MI. In 
fact, trained pharmacists have been more effective than non-
trained pharmacists in helping people to quit smoking. This 
can be a good starting point for future studies to build on.
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